Life Science Leader - Home Page
Life Science Leader - thought leadership articles and discussions about the current life science industry
About Life Science Leader
Life Science Leader is an essential business publication for life science executives who work at everything from emerging biotechs to large pharmaceutical companies. Our content is designed to inform readers of industry best practices and motivate them to …
Industry Leader - Life Science Leader
Industry Leader articles are written by executives at biopharma companies, consultancies, research firms, and companies that provide services or products to sponsors. The topics are nonpromotional and focused on industrywide business issues. Optimism For Life Sciences Growth Amid Policy Shifts In ...
Life Science Leader: About Us
Life Science Leader is an essential business publication for life science executives who work at everything from emerging biotechs to large pharmaceutical companies. Our content is designed to inform readers of industry best practices and motivate them to …
Optimism For Life Sciences Growth Amid Policy Shifts In 2025
2024年12月11日 · By Arda Ural, Ph.D. Arda Ural, Ph.D. Key innovation, technology, dealmaking and policy considerations are reshaping the industry’s future. While patent expirations of $300b will continue to put pressure on growth, robust innovation likely will partially offset top-line erosion.
Life Science Leader - Home Page
Life sciences legal departments can do more to improve financial efficiency across an organization. This article includes insights from an Ernst & Young survey of multinational corporations across the pharmaceutical, consumer health, and medical device industries.
Building New Solutions For 2023 In Manufacturing And Supply Chain
2022年12月1日 · By Ben Comer, Chief Editor, Life Science Leader. Manufacturing and scaling the spate of new advanced therapeutics in development will continue to present a challenge in 2023, particularly as key supplies and ingredients remain sluggish to procure.
EXECUTIVE INTERVIEWS - Life Science Leader
Inozyme's CEO and chairman Douglas Treco shares his thoughts about the rousing success of the Orphan Drug Act, but cautions rare disease drug developers against sky high and inaccessible drug pricing practices. NORD's president and CEO, Peter Saltonstall, offers details on the organization's current ...
The Future Of Life Sciences Manufacturing And The Supply Chain
2022年1月4日 · By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. We witnessed some amazing accomplishments by the biopharmaceutical industry last year. Just think about all those clinical trials that were executed for the multiple vaccines that we now have access to in world-record time.
Leveling Up By Challenging Assumptions - Life Science Leader
2022年6月1日 · By Ben Comer, Chief Editor, Life Science Leader. One year after Rami Elghandour joined Arcellx, Inc., a cell therapy company based in Gaithersburg, MD, and Foster City, CA, as the company’s new chairman and CEO, he took the company public, netting $128 million and funding operations into the second half of 2023.